Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"24,400 (16,245, 35,259)","54.3% (46.0%, 65.6%)","68.8% (53.5%, 83.2%)","15.2% (11.0%, 26.9%)","51.8% (43.4%, 62.9%)","19.0 (16.1, 23.0)","24.1 (18.7, 29.1)","5.3 (3.8, 9.4)","18.1 (15.2, 22.0)",,,,,
"(p=None, None), q=(None, None), c=0.500)","20,810 (12,264, 30,475)","63.3% (51.2%, 79.6%)","41.5% (29.7%, 57.4%)","8.7% (6.3%, 11.8%)","60.6% (49.0%, 76.5%)","22.2 (17.9, 27.9)","14.5 (10.4, 20.1)","3.1 (2.2, 4.1)","21.2 (17.2, 26.8)","-15.3% (-28.7%, -5.1%)","16.3% (7.8%, 30.3%)","-39.8% (-51.9%, -25.5%)","-38.2% (-67.0%, -6.0%)","16.6% (8.0%, 30.7%)"
"(p=None, None), q=(None, None), c=0.750)","21,262 (12,247, 30,835)","63.0% (50.1%, 80.1%)","40.3% (29.4%, 56.4%)","8.3% (6.1%, 10.6%)","60.4% (48.0%, 77.4%)","22.0 (17.5, 28.0)","14.1 (10.3, 19.7)","2.9 (2.1, 3.7)","21.1 (16.8, 27.1)","-13.7% (-27.0%, -3.1%)","15.7% (6.0%, 24.8%)","-41.5% (-54.9%, -26.8%)","-41.4% (-67.7%, -17.7%)","16.3% (6.3%, 25.7%)"
"(p=None, None), q=(None, None), c=1.000)","21,361 (12,180, 30,455)","63.5% (51.9%, 81.0%)","39.8% (28.9%, 56.2%)","8.0% (5.8%, 10.4%)","60.9% (49.6%, 78.4%)","22.2 (18.2, 28.3)","13.9 (10.1, 19.7)","2.8 (2.0, 3.6)","21.3 (17.4, 27.4)","-13.2% (-27.4%, -3.4%)","16.7% (7.1%, 28.5%)","-42.2% (-55.2%, -27.1%)","-43.2% (-69.0%, -19.8%)","17.4% (7.3%, 29.6%)"
